Selected Publications
Landsburg DJ, Frigault MJ, Heim M, Foley SR, Hill B, Schofield G, Jacobson CA, Jaglowski S, Locke FL, Ram R, Riedell PA, Shah G, Popplewell LL, Tiwari R, Lim S, Majdan M, Masood A, Pasquini M, Turtle CJ.: Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry J Immunother Cancer 13 (2): e009890,2025.
Schneider M, Nasta SD, Barta SK, Chong EA, Svoboda J, Schuster SJ, Landsburg DJ.: Analysis of Histologic, Immunohistochemical and Genomic Features of Large B Cell Lymphoma Tumors May Predict Response to Polatuzumab Vedotin Based Therapy in Patients With Relapsed/Refractory Disease Clin Lymphoma Myeloma Leuk 25 (1): 45-51,2025.
Maillie L, Nasta SD, Svoboda J, Barta SK, Chong EA, Garfall AL, Gill SI, Porter DL, Schuster SJ, Catania C, Frey NV, Landsburg DJ.: Prolonged Neurologic Symptoms Following Immune Effector Cell-Associated Neurotoxicity Syndrome in Patients With Large B-cell Lymphoma Treated With Chimeric Antigen Receptor-Modified T Cell Therapy Transplant Cell Ther 00912-1. (25): S2666-6367,2025.
Landsburg, DJ: Improving Cure Rates for Patients with Newly Diagnosed Large B-Cell Lymphomas: Targeted Therapies for High-Risk Pathologic Subgroups as Defined by Clinical Laboratory Testing Cancers (Basel) 17 (1): 18,2024.
Frost, Benjamin F., Frey, Noelle, Hexner, Elizabeth O., Schuster, Stephen J., Nasta, Sunita D., Loren, Alison W, Svoboda, Jakub, Landsburg, Daniel J., Levine, Bruce, Fraietta, Joseph A., Melenhorst, J. Joseph, Veloso, Elizabeth, Hwang, Wei-Ting, June, Carl H., Porter, David L., Gill, Saar: Curing CLL: Long-Term Outcomes of Chronic Lymphocytic Leukemia Patients with at Least One Year of Response to CART-19 Therapy Blood. American Society of Hematology Annual Meeting, San Diego, CA. 144 (Supplement 1): 588-588,2024.
Elghawy, O., Thomas, C. J., Carter, J. S., Landsburg, D. J., Svoboda, J., Kim, E., Rook, A., Chung, J., Plastaras, J. P., LaRiviere, M., Hubbeling, H., Chelius, M., Nasta, S. D., Chong, E. A., Schuster, S. J., Barta, S. K.: Single Institution Experience of Pembrolizumab for Patients with Relapsed or Refractory Mycosis Fungoides or Sezary Syndrome Clinical Lymphoma Myeloma & Leukemia, American Society of Hematology Annual Meeting, San Diego, CA. 24 : S522-S522,2024.
Dave, Nikita, Carvajal, Veronica, Carter, Jordan, Tsai, Donald Edward, Schuster, Stephen J., Gerson, James, Barta, Stefan K., Svoboda, Jakub, Chong, Elise A., Landsburg, Daniel J., Nasta, Sunita D.: Outcomes in Primary CNS Lymphoma: A Single Institution Experience from the Abramson Cancer Center at the University of Pennsylvania Blood, American Society of Hematology Annual Meeting, San Diego, CA. 144 (Supplement 1): 1699-1699,2024.
Carulli, Alison, Elliott, Hayden, Mangan, Brendan, Whittenburg, James, Chong, Elise A., Nasta, Sunita D., Svoboda, Jakub, Barta, Stefan K., Porter, David L., Carter, Jordan S., Cook, Michael Roderick, Hossain, Nasheed, Gill, Saar, Garfall, Alfred L., Catania, Christopher, Kucharczuk, Colleen R., Schuster, Stephen J., Frey, Noelle, Landsburg, Daniel J.: Comparison of CRS- and Icans-Related Outcomes for Large B Cell Lymphoma Patients Treated with Commercial Axicabtagene Ciloleucel with or without Prophylactic Dexamethasone Blood, American Society of Hematology, San Diego, CA. 144 (Supplement 1): 2275-2275,2024.
Brooks, Taylor R., Zabor, Emily C., Bedelu, Yohana B., Dave, Nikita, Landsburg, Daniel J., Nedved, Adrienne N., Wang, Yucai, Reinert, Catherine, Major, Ajay, Sears-Smith, Megan, Ghosh, Nilanjan, Salafian, Kiarash, Ayers, Emily, Miller, Jordan, Grover, Natalie, Peterson, Chelsea, Khan, Cyrus, Bliven, Sean Patrick, Narkhede, Mayur S., Ho, Carrie I, Smith, Stephen D., Gibson, Alyssa, Kline, Justin, Sundaram, Suchitra, Brody, Joshua, Baron, Kelsey, Hu, Boyu, Trotier, Daniel, Pophali, Priyanka A., Yang, XI, Karimi, Yasmin H., McKenna, Marshall, Tiger, Yun Kyoung, Niu, Alex, Hernandez-Ilizaliturri, Francisco, Garza Morales, Rodolfo, Munoz, Javier, Chinyengetere, Fadzai, Dave, Sandeep, Abdel-Razeq, Nayef, Alhaj Moustafa, Muhamad, Caimi, Paolo F., Hill, Brian T.: Real-World Outcomes with Bispecific T-Cell Engagers (REALBiTE) for Relapsed or Refractory Large B-Cell Lymphoma: A Multi-Center, Retrospective Cohort Study Blood, American Society of Hematology Annual Meeting, San Diego, CA. 144 (Supplement 1): 111-111,2024.
Barta, Stefan K., Ruella, Marco, Schuster, Stephen J., Svoboda, Jakub, Carter, Jordan, Chong, Elise A., Landsburg, Daniel J., Nasta, Sunita D., Thomas, Colin, Patel, Ruchi P., Ghilardi, Guido, Porazzi, Patrizia, Yang, Steven, Qian, Dean, Pajarillo, Raymone, Zhang, Yunlin, Nimmagadda, Aditya, Vu, Trang, Peddada, Lavanya, Snook, Adam E., Siciliano, Nicholas A., Mazanet, Rosemary: CD5-Deleted Chimeric Antigen Receptor Cells (Senza5™ CART5) to Enhance Immunotherapy Against T-Cell Non-Hodgkin Lymphoma: A First-in-Human Phase I Clinical Trial Blood, American Society of Hematology Annual Meeting, San Diego, CA. 144 (Supplement 1): 7221-7221,2024.
Academic Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-182
3400 Civic Center Boulevard
Philadelphia,
PA
19104
Phone: 215-615-7361
Patient appointments: 800-789-7366